CDTX
Cidara Therapeutics (CDTX)
$05
About Cidara Therapeutics (CDTX)
Cidara Therapeutics, Inc. is a biotechnology company, which engages in the discovery, development, and commercialization of therapeutics for patients facing serious diseases, specifically oncology and infectious diseases. Its product pipeline includes Rezafungin Acetate and Cloudbreak. The company was founded by Kevin M. Forrest, Kevin J. Judice, and H. Shaw Warren in December 2012 and is headquartered in San Diego, CA.
Details
Daily high
$22.62
Daily low
$22.04
Price at open
$22.31
52 Week High
$28.42
52 Week Low
$10.00
Market cap
241.5M
Dividend yield
0.00%
Volume
60,726
Avg. volume
101,099
P/E ratio
-.74
Cidara Therapeutics News
Details
Daily high
$22.62
Daily low
$22.04
Price at open
$22.31
52 Week High
$28.42
52 Week Low
$10.00
Market cap
241.5M
Dividend yield
0.00%
Volume
60,726
Avg. volume
101,099
P/E ratio
-.74